Intratubular germ cell neoplasia of the human testis: heterogeneous protein expression and relation to invasive potential
暂无分享,去创建一个
Lee B. Smith | R. Sharpe | K. Grigor | L. Looijenga | H. Stoop | P. Saunders | W. Wallace | C. Kelnar | R. Mitchell | K. Wolffenbuttel | M. O’Donnell | M. Camacho-Moll | R. Donat | Joni Macdonald | R. Anderson | C. Kelnar | M. O'Donnell | M. E. Camacho-Moll
[1] P. Fowler,et al. Development of the human fetal testis. , 2014, Annales d'endocrinologie.
[2] E. R. Meyts,et al. Dysregulation of the mitosis–meiosis switch in testicular carcinoma in situ , 2013, The Journal of pathology.
[3] Yao-Tseng Chen,et al. Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas. , 2013, Cancer immunity.
[4] N. Skakkebæk,et al. Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells , 2010, British Journal of Cancer.
[5] R. Sharpe,et al. Xenografting of human fetal testis tissue: a new approach to study fetal testis development and germ cell differentiation , 2010, Human reproduction.
[6] R. Sharpe,et al. Germ cell differentiation in the marmoset (Callithrix jacchus) during fetal and neonatal life closely parallels that in the human , 2008, Human reproduction.
[7] L. Looijenga,et al. Chromosomes and Expression in Human Testicular Germ‐Cell Tumors , 2007, Annals of the New York Academy of Sciences.
[8] E. Rajpert-De Meyts. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. , 2006, Human reproduction update.
[9] E. Steyerberg,et al. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. , 2005, The Journal of clinical endocrinology and metabolism.
[10] H. Leffers,et al. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours , 2005, Histopathology.
[11] Yun-Fai Chris Lau,et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. , 2005, Human pathology.
[12] L. Looijenga,et al. Testicular germ-cell tumours in a broader perspective , 2005, Nature Reviews Cancer.
[13] H. Leffers,et al. Transcription Factor AP-2γ Is a Developmentally Regulated Marker of Testicular Carcinoma In situ and Germ Cell Tumors , 2004, Clinical Cancer Research.
[14] Liang Cheng,et al. OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] P. Saunders,et al. Immunohistochemical Profiling of Germ Cells Within the Human Fetal Testis: Identification of Three Subpopulations , 2004, Biology of reproduction.
[16] H. Adami,et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[17] Christian Schwager,et al. Embryonic Stem Cell-Like Features of Testicular Carcinoma in Situ Revealed by Genome-Wide Gene Expression Profiling , 2004, Cancer Research.
[18] C. Bokemeyer,et al. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells , 2004, The Journal of pathology.
[19] N. Skakkebaek,et al. Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. , 2004, Human reproduction.
[20] J. Kononen,et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. , 2003, Cancer research.
[21] J. Bartek,et al. The emerging phenotype of the testicular carcinoma in situ germ cell , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[22] L. Brown,et al. Trends in the incidence of testicular germ cell tumors in the United States , 2003, Cancer.
[23] L. Looijenga,et al. VASA Is a Specific Marker for Both Normal and Malignant Human Germ Cells , 2002, Laboratory Investigation.
[24] P. Chomez,et al. MAGE‐A4, a germ cell specific marker, is expressed differentially in testicular tumors , 2001, Cancer.
[25] B. Quade,et al. The human VASA gene is specifically expressed in the germ cell lineage. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[26] A. Renshaw,et al. Evaluation of Cyclin Expression in Testicular Germ Cell Tumors: Cyclin E Correlates with Tumor Type, Advanced Clinical Stage, and Pulmonary Metastasis , 2000, Modern Pathology.
[27] P. Albers,et al. Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors. , 1996, The Journal of urology.
[28] N. Skakkebaek,et al. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[29] A. Norton,et al. Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues , 1994, The Journal of pathology.
[30] N. Skakkebaek,et al. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. , 1987, International journal of andrology.
[31] J. Hustin,et al. Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. , 1987, International journal of andrology.
[32] P. W. Adams,et al. VITAMIN B6, DEPRESSION, AND ORAL CONTRACEPTION , 1974 .
[33] N. Skakkebæk. POSSIBLE CARCINOMA-IN-SITU OF THE TESTIS , 1972 .
[34] N. Skakkebaek,et al. Possible carcinoma-in-situ of the testis. , 1972, Lancet.